Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 12, 2018
Cladribine: mechanisms and mysteries in multiple sclerosis
Benjamin Meir Jacobs, Francesca Ammoscato, Gavin Giovannoni, et al.
Journal of Clinical Gastroenterology
|
September 8, 2012
Microbiota, innate immune system, and gastrointestinal muscle: ongoing studies
Ivan Tattoli, Chiara Petitta, Annunziata Scirocco, et al.
Journal of Neurology
|
March 19, 2018
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
Bryan Ceronie, Benjamin M Jacobs, David Baker, et al.
Free Radical Biology & Medicine
|
October 10, 2012
Antioxidants counteract lipopolysaccharide-triggered alterations of human colonic smooth muscle cells
Paola Matarrese, Chiara Petitta, Annunziata Scirocco, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 23, 2020
CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
Saúl Reyes, Ide Smets, David Holden, et al.
Journal of Cellular Physiology
|
January 30, 2010
Exposure of Toll-like receptors 4 to bacterial lipopolysaccharide (LPS) impairs human colonic smooth muscle cell function
Annunziata Scirocco, Paola Matarrese, Chiara Petitta, et al.
Multiple Sclerosis and Related Disorders
|
December 6, 2021
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study
Ide Smets, David Holden, Lucia Bianchi, et al.
Fibrogenesis & Tissue Repair
|
July 10, 2013
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis
Paolo Biancheri, Sylvia Lf Pender, Francesca Ammoscato, et al.
European Journal of Immunology
|
December 17, 2013
Absence of a role for interleukin-13 in inflammatory bowel disease
Paolo Biancheri, Antonio Di Sabatino, Francesca Ammoscato, et al.
Clinical Immunology (Orlando, Fla.)
|
October 20, 2024
Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells
Francesca Ammoscato, Mohammad Wafa, Justyna Skonieczna, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 12, 2018
Cladribine: mechanisms and mysteries in multiple sclerosis
Benjamin Meir Jacobs, Francesca Ammoscato, Gavin Giovannoni, et al.
Journal of Clinical Gastroenterology
|
September 8, 2012
Microbiota, innate immune system, and gastrointestinal muscle: ongoing studies
Ivan Tattoli, Chiara Petitta, Annunziata Scirocco, et al.
Journal of Neurology
|
March 19, 2018
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
Bryan Ceronie, Benjamin M Jacobs, David Baker, et al.
Free Radical Biology & Medicine
|
October 10, 2012
Antioxidants counteract lipopolysaccharide-triggered alterations of human colonic smooth muscle cells
Paola Matarrese, Chiara Petitta, Annunziata Scirocco, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 23, 2020
CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
Saúl Reyes, Ide Smets, David Holden, et al.
Journal of Cellular Physiology
|
January 30, 2010
Exposure of Toll-like receptors 4 to bacterial lipopolysaccharide (LPS) impairs human colonic smooth muscle cell function
Annunziata Scirocco, Paola Matarrese, Chiara Petitta, et al.
Multiple Sclerosis and Related Disorders
|
December 6, 2021
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study
Ide Smets, David Holden, Lucia Bianchi, et al.
Fibrogenesis & Tissue Repair
|
July 10, 2013
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis
Paolo Biancheri, Sylvia Lf Pender, Francesca Ammoscato, et al.
European Journal of Immunology
|
December 17, 2013
Absence of a role for interleukin-13 in inflammatory bowel disease
Paolo Biancheri, Antonio Di Sabatino, Francesca Ammoscato, et al.
Clinical Immunology (Orlando, Fla.)
|
October 20, 2024
Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells
Francesca Ammoscato, Mohammad Wafa, Justyna Skonieczna, et al.
Page
of 2